Category:
Sera and Vaccines
CAS NO:
2212020-52-3
Standard:
In-house Standards,
Orforglipron is a GLP-1 receptor agonist that lowers blood glucose levels by stimulating insulin secretion and suppressing glucagon secretion, thereby treating type 2 diabetes and obesity/overweight. Orforglipron also delays gastric emptying, which positively regulates appetite and food intake, ultimately leading to weight loss.